Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs ...

As the year gets underway, analysts and biotech executives highlight cell therapy’s pivot from oncology to autoimmune ...

Just a week before he vacates the White House, President Biden signed the Interim Final Rule on Artificial Intelligence ...

BMO Capital analyst Evan Seigerman has maintained their neutral stance on MRK stock, giving a Hold rating on January 10.Stay Ahead of the ...

Biden decided not to include Israel among the countries exempt from the approval process, namely Australia, Belgium, Canada, ...

Gilead Sciences said on Saturday that it entered into a partnership with Denmark's LEO Pharma to develop programs to treat ...

Walgreens maintained its fiscal 2025 adjusted earnings guidance, but did not include a sales outlook in its release.

When the BIOSECURE Act hit a setback and missed the chance of becoming law in 2024, the deceleration of the draft legislation ...